Wellington Management Group LLP Has $22.61 Million Stock Holdings in Tempus AI, Inc. $TEM

Wellington Management Group LLP trimmed its position in Tempus AI, Inc. (NASDAQ:TEM) by 24.1% during the second quarter, Holdings Channel reports. The firm owned 390,241 shares of the company’s stock after selling 123,748 shares during the quarter. Wellington Management Group LLP’s holdings in Tempus AI were worth $22,607,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the company. Royal Bank of Canada increased its position in Tempus AI by 201.2% during the first quarter. Royal Bank of Canada now owns 25,988 shares of the company’s stock worth $1,253,000 after buying an additional 17,359 shares during the last quarter. Rhumbline Advisers acquired a new stake in shares of Tempus AI in the first quarter valued at approximately $116,000. Prudential Financial Inc. bought a new position in shares of Tempus AI during the 2nd quarter worth approximately $276,000. Russell Investments Group Ltd. boosted its stake in shares of Tempus AI by 21.3% during the 2nd quarter. Russell Investments Group Ltd. now owns 6,527 shares of the company’s stock worth $415,000 after acquiring an additional 1,146 shares during the period. Finally, Invesco Ltd. increased its holdings in shares of Tempus AI by 2,926.6% during the 2nd quarter. Invesco Ltd. now owns 211,621 shares of the company’s stock worth $13,446,000 after acquiring an additional 204,629 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, CFO James Rogers sold 26,313 shares of the stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $60.00, for a total transaction of $1,578,780.00. Following the transaction, the chief financial officer owned 106,024 shares in the company, valued at $6,361,440. This represents a 19.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 250,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $42.06, for a total transaction of $10,515,000.00. Following the transaction, the chief executive officer directly owned 200,000 shares in the company, valued at $8,412,000. This represents a 55.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,043,988 shares of company stock valued at $56,963,417 in the last three months. 24.26% of the stock is owned by insiders.

Tempus AI Stock Down 0.1%

TEM stock opened at $64.62 on Friday. The company has a debt-to-equity ratio of 3.06, a current ratio of 3.30 and a quick ratio of 3.16. The stock has a market capitalization of $11.66 billion, a price-to-earnings ratio of -44.87 and a beta of 3.72. The business’s fifty day moving average price is $55.77 and its two-hundred day moving average price is $52.13. Tempus AI, Inc. has a fifty-two week low of $40.77 and a fifty-two week high of $104.32.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.10. The company had revenue of $382.49 million during the quarter, compared to the consensus estimate of $379.69 million. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The company’s revenue was up 21.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.22) earnings per share. On average, equities analysts anticipate that Tempus AI, Inc. will post -1.38 earnings per share for the current year.

Wall Street Analyst Weigh In

TEM has been the topic of a number of research analyst reports. BTIG Research increased their price target on Tempus AI from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Cantor Fitzgerald initiated coverage on shares of Tempus AI in a report on Wednesday. They issued an “overweight” rating and a $80.00 price objective on the stock. TD Cowen restated a “buy” rating on shares of Tempus AI in a research note on Wednesday, July 15th. Stifel Nicolaus reduced their target price on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating for the company in a report on Monday, August 3rd. Finally, Wolfe Research initiated coverage on shares of Tempus AI in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Eleven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Tempus AI presently has an average rating of “Moderate Buy” and a consensus price target of $68.93.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.